FFA
RPRX icon

Farther Finance Advisors’s Royalty Pharma RPRX Stock Holding History

Farther Finance Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$182K Sell
3,247
-15
-0.5% -$781 ﹤0.01% 2309
2026
Q1 		$158K Buy
3,262
+1,147
+54% +$50.2K ﹤0.01% 2188
2025
Q4 		$81.7K Buy
2,115
+55
+3% +$2.1K ﹤0.01% 2471
2025
Q3 		$72.7K Buy
2,060
+632
+44% +$22.9K ﹤0.01% 2232
2025
Q2 		$51.5K Buy
1,428
+760
+114% +$25.2K ﹤0.01% 2120
2025
Q1 		$20.8K Buy
668
+31
+5% +$983 ﹤0.01% 2368
2024
Q4 		$16.3K Buy
637
+222
+53% +$5.89K ﹤0.01% 2172
2024
Q3 		$11.8K Sell
415
-30
-7% -$831 ﹤0.01% 2306
2024
Q2 		$11.7K Sell
445
-40
-8% -$1.11K ﹤0.01% 2018
2024
Q1 		$14.5K Sell
485
-39
-7% -$1.15K ﹤0.01% 1605
2023
Q4 		$14.7K Buy
524
+497
+1,841% +$13.7K ﹤0.01% 1441
2023
Q3 		$733 Buy
27
+14
+108% +$416 ﹤0.01% 2163
2023
Q2 		$400 Sell
13
-25
-66% -$847 ﹤0.01% 2215
2023
Q1 		$1.37K Buy
38
+33
+660% +$1.22K ﹤0.01% 1764
2022
Q4 		$198 Buy
+5
New +$209 ﹤0.01% 2041

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Farther Finance Advisors's RPRX Position: Q2 2026 in Review

Farther Finance Advisors reduced its Royalty Pharma (RPRX) stake by 0.46% in Q2 2026, selling an estimated $781 and leaving 3,247 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #2309.

Farther Finance Advisors first reported a position in RPRX in Q4 2022 and has held it in 15 quarters since. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Farther Finance Advisors held 3,247 shares of Royalty Pharma worth $182K as of Q2 2026.
  • Farther Finance Advisors sold 15 Royalty Pharma shares in Q2 2026, an estimated $781.
  • Royalty Pharma made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #2309 holding.
  • Farther Finance Advisors first reported a position in Royalty Pharma in Q4 2022 and has held it in 15 quarters since.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.